108 related articles for article (PubMed ID: 37248036)
1. Salivary 3-methoxy-4-hydroxyphenylglycol and MRI-based volume change of the precuneus in community-dwelling elderly people.
Ohishi-Fukuchi J; Imamura Y; Orihashi R; Kunitake H; Kunitake Y; Tateishi H; Yamada S; Monji A; Mizoguchi Y
Psychogeriatrics; 2023 Jul; 23(4):675-681. PubMed ID: 37248036
[TBL] [Abstract][Full Text] [Related]
2. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population.
Li GY; Watanabe I; Kunitake Y; Sugataka K; Muraoka T; Kojima N; Kawashima T; Yamada S
Psychiatry Clin Neurosci; 2008 Oct; 62(5):562-7. PubMed ID: 18950376
[TBL] [Abstract][Full Text] [Related]
3. Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubała WJ; Landowski J; Wielgomas B; Czarnowski W
J Affect Disord; 2014 Jun; 161():4-7. PubMed ID: 24751300
[TBL] [Abstract][Full Text] [Related]
4. Belief in life after death, salivary 3-methoxy-4-hydroxyphenylglycol, and well-being among older people without cognitive impairment dwelling in rural Japan.
Imamura Y; Mizoguchi Y; Nabeta H; Matsushima J; Watanabe I; Kojima N; Kawashima T; Yamada S; Monji A
Int J Geriatr Psychiatry; 2015 Mar; 30(3):256-64. PubMed ID: 24760761
[TBL] [Abstract][Full Text] [Related]
5. Association of saliva 3-methoxy-4-hydroxyphenylglycol levels and a later depressive state in older subjects living in a rural community: 3-year follow-up study.
Watanabe I; Li GY; Imamura Y; Nabeta H; Kunitake Y; Ishii H; Haraguchi M; Kojima N; Yamada S
Int J Geriatr Psychiatry; 2012 Mar; 27(3):321-6. PubMed ID: 21538541
[TBL] [Abstract][Full Text] [Related]
6. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
Egami M; Imamura Y; Nabeta H; Mizoguchi Y; Yamada S
Hum Psychopharmacol; 2013 Jan; 28(1):7-14. PubMed ID: 23124792
[TBL] [Abstract][Full Text] [Related]
7. Association between the scores on the general health questionnaire-28 and the saliva levels of 3-methoxy-4-hydroxyphenylglycol in normal volunteers.
Li GY; Ueki H; Yamamoto Y; Yamada S
Biol Psychol; 2006 Aug; 73(2):209-11. PubMed ID: 16472905
[TBL] [Abstract][Full Text] [Related]
8. Association between cortisol and aging-related hippocampus volume changes in community-dwelling older adults: a 7-year follow-up study.
Orihashi R; Imamura Y; Yamada S; Monji A; Mizoguchi Y
BMC Geriatr; 2022 Sep; 22(1):765. PubMed ID: 36131257
[TBL] [Abstract][Full Text] [Related]
9. Association Between sTREM2, an Immune Biomarker of Microglial Activation, and Aging-Related Brain Volume Changes in Community-Dwelling Older Adults: A 7-Year Follow-Up Study.
Orihashi R; Mizoguchi Y; Imamura Y; Yamada S; Monji A
Front Aging Neurosci; 2021; 13():665612. PubMed ID: 33981209
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin and elderly MRI-based hippocampus and amygdala volume: a 7-year follow-up study.
Orihashi R; Mizoguchi Y; Imamura Y; Yamada S; Ueno T; Monji A
Brain Commun; 2020; 2(2):fcaa081. PubMed ID: 32954331
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the noradrenergic system in performance on a continuous task requiring effortful attention.
Li GY; Ueki H; Kawashima T; Sugataka K; Muraoka T; Yamada S
Neuropsychobiology; 2004; 50(4):336-40. PubMed ID: 15539866
[TBL] [Abstract][Full Text] [Related]
12. Baseline saliva level of 3-methoxy-4-hydroxyphenylglycole (MHPG) associates with a consequent cognitive decline in non-demented elderly subjects: three-years follow-up study.
Watanabe I; Li GY; Imamura Y; Nabeta H; Kunitake Y; Ishii H; Haraguchi M; Furukawa Y; Tateishi H; Kojima N; Nizoguchi Y; Yamada S
Psychiatry Res; 2012 Feb; 195(3):125-8. PubMed ID: 21802746
[TBL] [Abstract][Full Text] [Related]
13. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
14. No association of both serum pro-brain-derived neurotrophic factor (proBDNF) and BDNF concentrations with depressive state in community-dwelling elderly people.
Ohto A; Mizoguchi Y; Imamura Y; Kojima N; Yamada S; Monji A
Psychogeriatrics; 2021 Jul; 21(4):503-513. PubMed ID: 33878808
[TBL] [Abstract][Full Text] [Related]
15. Increase in cerebrospinal fluid and plasma levels of 3-methoxy-4-hydroxyphenylglycol in acute stroke.
Kanda T; Azuma K; Sakai F; Tazaki Y
Stroke; 1991 Dec; 22(12):1525-9. PubMed ID: 1962327
[TBL] [Abstract][Full Text] [Related]
16. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.
Raskind MA; Peskind ER; Halter JB; Jimerson DC
Arch Gen Psychiatry; 1984 Apr; 41(4):343-6. PubMed ID: 6703854
[TBL] [Abstract][Full Text] [Related]
17. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
18. Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease.
Lawlor BA; Bierer LM; Ryan TM; Schmeidler J; Knott PJ; Williams LL; Mohs RC; Davis KL
Biol Psychiatry; 1995 Aug; 38(3):185-8. PubMed ID: 7578662
[TBL] [Abstract][Full Text] [Related]
19. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.
DeCarli C; Massaro J; Harvey D; Hald J; Tullberg M; Au R; Beiser A; D'Agostino R; Wolf PA
Neurobiol Aging; 2005 Apr; 26(4):491-510. PubMed ID: 15653178
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
